ArticleBreast cancer research : BCR2025

Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancer.

Camille Jouines et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.